IRIS UniCatt

Locatelli, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 27.366
NA - Nord America 8.765
SA - Sud America 6.353
EU - Europa 6.166
AF - Africa 642
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 49.323
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 13.884
US - Stati Uniti d'America 8.141
CN - Cina 7.369
BR - Brasile 5.362
IT - Italia 1.414
ID - Indonesia 1.277
IE - Irlanda 1.181
KR - Corea 1.009
IN - India 868
RU - Federazione Russa 761
DE - Germania 733
VN - Vietnam 577
HK - Hong Kong 509
GB - Regno Unito 441
AR - Argentina 401
BD - Bangladesh 385
SE - Svezia 361
IQ - Iraq 316
MX - Messico 246
FR - Francia 223
CA - Canada 198
ZA - Sudafrica 197
FI - Finlandia 168
AT - Austria 150
TR - Turchia 145
PK - Pakistan 143
VE - Venezuela 140
JP - Giappone 134
EC - Ecuador 132
UA - Ucraina 131
PL - Polonia 124
NL - Olanda 108
SA - Arabia Saudita 108
MA - Marocco 100
CZ - Repubblica Ceca 89
CO - Colombia 86
ES - Italia 78
JO - Giordania 77
UZ - Uzbekistan 77
KE - Kenya 73
PY - Paraguay 68
NP - Nepal 60
EG - Egitto 53
CL - Cile 52
AZ - Azerbaigian 50
AE - Emirati Arabi Uniti 46
PE - Perù 41
UY - Uruguay 41
DZ - Algeria 37
JM - Giamaica 37
KZ - Kazakistan 36
IL - Israele 35
TN - Tunisia 35
ET - Etiopia 33
OM - Oman 33
CR - Costa Rica 31
IR - Iran 30
LB - Libano 27
BO - Bolivia 24
CH - Svizzera 23
SN - Senegal 23
BH - Bahrain 21
PH - Filippine 21
BG - Bulgaria 20
HN - Honduras 20
NG - Nigeria 20
PA - Panama 20
DO - Repubblica Dominicana 19
PT - Portogallo 19
BY - Bielorussia 17
LT - Lituania 17
SY - Repubblica araba siriana 17
AU - Australia 16
AL - Albania 15
CI - Costa d'Avorio 15
PS - Palestinian Territory 15
TT - Trinidad e Tobago 15
BB - Barbados 14
GE - Georgia 14
BE - Belgio 13
RS - Serbia 12
KG - Kirghizistan 11
RO - Romania 11
MY - Malesia 10
AM - Armenia 8
GA - Gabon 8
KW - Kuwait 8
MD - Moldavia 8
TH - Thailandia 8
CG - Congo 7
GR - Grecia 7
LV - Lettonia 7
NI - Nicaragua 7
QA - Qatar 7
XK - ???statistics.table.value.countryCode.XK??? 7
AO - Angola 6
BN - Brunei Darussalam 6
DK - Danimarca 6
SK - Slovacchia (Repubblica Slovacca) 6
BW - Botswana 5
Totale 49.214
Salva come PNG Salva come JPEG
Città #
Singapore 5.652
Hefei 2.977
Ashburn 2.055
Jakarta 1.249
Dublin 1.178
Seoul 994
Kent 877
Los Angeles 550
Moscow 532
Hong Kong 498
Beijing 492
Hyderabad 483
São Paulo 452
Milan 422
Dallas 270
Washington 263
Nuremberg 252
New York 242
Rome 210
Ho Chi Minh City 209
Chicago 191
Frankfurt am Main 174
Rio de Janeiro 159
Santa Clara 147
Hanoi 124
Tokyo 120
Brooklyn 115
Chandler 112
Belo Horizonte 107
Brasília 102
Johannesburg 102
Munich 102
London 101
Baghdad 100
Seattle 100
Curitiba 90
Warsaw 88
Buffalo 87
Dhaka 86
San Francisco 84
Porto Alegre 81
Brno 79
Amman 74
Campinas 73
Nairobi 70
Boston 68
Atlanta 66
Montreal 66
Tashkent 66
Arezzo 64
Lappeenranta 63
Pune 63
Helsinki 59
Mexico City 58
Vienna 55
Guayaquil 54
Paris 52
Shanghai 52
Erbil 49
Phoenix 49
Buenos Aires 47
Baku 45
Guarulhos 45
Ribeirão Preto 45
Jacksonville 44
Chennai 43
Quito 43
Salvador 43
Goiânia 42
Bologna 41
Caracas 40
Toronto 39
Busto Arsizio 38
Council Bluffs 38
Houston 38
Istanbul 38
Montevideo 38
Cape Town 37
Lahore 37
Asunción 36
Caxias do Sul 36
Fortaleza 36
Guangzhou 36
Recife 35
Amsterdam 34
Denver 34
Riyadh 34
Stockholm 33
Düsseldorf 32
Turku 32
Lima 31
Maceió 31
Manchester 31
Uberlândia 31
Ankara 30
Jeddah 30
Manaus 30
Mumbai 30
Sorocaba 30
São José dos Campos 29
Totale 24.871
Salva come PNG Salva come JPEG
Nome #
Cilostazol promotes angiogenesis after peripheral ischemia through a VEGF-dependent mechanism 232
Advancements and challenges in CAR T cell therapy in autoimmune diseases 144
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 136
Cyclooxygenase-2 (COX-2) inhibition constrains indoleamine 2,3-dioxygenase 1 (IDO1) activity in acute myeloid leukaemia cells 134
Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study 122
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 121
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma. Reply 114
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy 105
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor 103
KRAS and CREBBP mutations: A relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia 103
Strategy for a multicenter phase I clinical trial to evaluate globin gene transfer in beta-thalassemia 102
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial 102
How I treat relapsed childhood acute lymphoblastic leukemia 102
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia 99
Dasatinib in the Management of Pediatric Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia 97
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma 97
Proteomics study of peripheral blood mononuclear cells in down syndrome children 97
Polyomavirus JC-targeted T-cell therapy for progressive multiple leukoencephalopathy in a hematopoietic cell transplantation recipient 93
Humoral and T-Cell Immune Response After 3 Doses of Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines in Fragile Patients: The Italian VAX4FRAIL Study 92
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma 92
Usefulness of 18F-FDG PET/CT in an Unusual Case of Solid-Pseudopapillary Pancreatic Tumor in Childhood With Aggressive Behavior 88
Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS 86
Identification of a new HLA-B*44 allele, HLA-B*44:02:68, by next generation sequencing 85
CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia 84
Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response 84
Hypodiploidy has unfavorable impact on survival in pediatric acute myeloid leukemia: An I-BFM Study Group collaboration 83
MicroRNAs-Proteomic Networks Characterizing Human Medulloblastoma-SLCs 83
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia 79
Genomic complexity and dynamics of clonal evolution in childhood acute myeloid leukemia studied with whole-exome sequencing 78
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study 78
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease 78
AMBRA1 regulates cyclin D to guard S-phase entry and genomic integrity 78
Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS 76
The role of interferon-gamma and its signaling pathway in pediatric hematological disorders 75
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 74
Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival 73
First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha-mannosidosis 72
The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx) 72
Impact of HLA mismatch direction on outcomes after umbilical cord blood transplantation for hematological malignant disorders: a retrospective Eurocord-EBMT analysis 71
Busulfan–fludarabine- or treosulfan–fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties 70
Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches 70
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 70
Outcome of children with acute leukemia given HLA-haploidentical HSCT after ab T-cell and B-cell depletion 69
T lymphocytes against solid malignancies: Winning ways to defeat tumours 69
Exagamglogene Autotemcel for Severe Sickle Cell Disease 69
Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant 69
A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients 68
TFG binds LC3C to regulate ULK1 localization and autophagosome formation 68
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications 67
Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference 67
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 67
Inhibition of natural killer cell cytotoxicity by interleukin-6: Implications for the pathogenesis of macrophage activation syndrome 66
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune Deficiencies 66
Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience 66
Outcome of very late relapse in children with acute lymphoblastic leukemia 66
Correlation of rhinovirus load in the respiratory tract and clinical symptoms in hospitalized immunocompetent and immunocompromised patients 66
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma 66
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 66
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 66
A case of SARS-CoV-2 Omicron reinfection resulting in a significant immunity boost in a paediatric patient affected by B-cell acute lymphoblastic leukemia 65
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL 65
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome 65
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors 65
T Cell Immunotherapy for Immune Reconstitution and GVHD Prevention After Allogeneic Hematopoietic Stem Cell Transplantation 64
A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children 64
ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas 64
Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors 63
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations 63
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia 63
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 63
Src nuclear localization and its prognostic relevance in human osteosarcoma 62
Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features 62
Transplantation in the onco-hematology field: focus on the manipulation of αβ and γδ T cells 62
Usefulness of 18F-FDG PET/CT in an unusual case of solid-pseudopapillary pancreatic tumor in childhood with aggressive behavior. 62
Clofarabine and Treosulfan as Conditioning for Matched Related and Unrelated Hematopoietic Stem Cell Transplantation: Results from the Clo3o Phase II Trial 61
Direct involvement of cranial nerve V at diagnosis in patients with diffuse intrinsic pontine glioma: A potential magnetic resonance predictor of short-term survival 61
Myelodysplastic syndromes in children 61
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells 61
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines 61
EZH2 down-regulation exacerbates lipid accumulation and inflammation in in vitro and in vivo NAFLD 61
Clinical, immunological, and molecular features of typical and atypical severe combined immunodeficiency: Report of the italian primary immunodeficiency network 61
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 61
Molecular and clinical heterogeneity in CLCN7-dependent osteopetrosis: report of 20 novel mutations 60
T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica 60
Effect of Blinatumomab vs Chemotherapy on Event-Free Survival among Children with High-risk First-Relapse B-Cell Acute Lymphoblastic Leukemia: A Randomized Clinical Trial 60
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: Consensus recommendations from the Acute Leukemia Working Party of the EBMT 60
αβT- and B-cell-depleted HLA-haploidentical hematopoietic stem cell transplantation in children with myelodysplastic syndromes 60
Case Report: Trichosporon japonicum Fungemia in a Pediatric Patient With Refractory Acute B Cell Lymphoblastic Leukemia 60
Juvenile myelomonocytic leukemia 60
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 59
Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT) 59
The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia 58
Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimen 58
CD28.OX40 co-stimulatory combination is high associated activity with of CAR.CD30 long in vivoT persistence cells and 58
Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study 58
Antifungal effect of all-trans retinoic acid against aspergillus fumigatus in vitro and in a pulmonary aspergillosis in vivo model 58
Haematopoetic stem cell transplantation for refractory autoimmune cytopenia 58
Epigenetic Profiling and Response to CD19 Chimeric Antigen Receptor T-Cell Therapy in B-Cell Malignancies 58
Cellular and molecular basis of haploidentical hematopoietic stem cell transplantation in the successful treatment of high-risk leukemias: role of alloreactive NK cells 58
Prolonged XPO1 inhibition is essential for optimal antileukemic activity in NPM1-mutated AML 58
Totale 7.635
Salva come PNG Salva come JPEG
Categoria #
all - tutte 325.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 325.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202156 0 0 0 0 0 7 9 2 14 8 16 0
2021/2022142 9 9 5 5 8 6 5 18 7 10 24 36
2022/20231.335 34 47 20 46 27 50 10 38 696 249 68 50
2023/20247.212 213 1.307 421 200 577 1.217 322 292 199 580 692 1.192
2024/202517.567 272 285 1.297 292 668 555 350 433 3.288 1.354 5.052 3.721
2025/202623.928 7.091 1.753 3.717 3.777 6.266 1.324 0 0 0 0 0 0
Totale 50.589